$TROV...financials, 3/12...from Yahoo message board....
mgm2020 • Mar 9, 2015 3:18 PM Flag
3users liked this postsusers disliked this posts2Reply
I just got off the phone with Amy Katerina at TROV IR---discussed many points with her....
First thing she told me was that TROV will be speaking at 3 key conferences in the next 8 weeks. The European Lung Conference is taking place in April and TROV will be there to speak about their lung cancer detection test. 2 of the bigger conferences this year are in May---AACR and ASCO, and TROV will be at both. When I pressed her about commercialization, what she said was that the tests ARE available right now, but when I asked her about insurance panel coverage and reimbursement she said that the tests are not similar to drugs, where the drug becomes approved and then the company goes panel to panel to be placed on formularies. The insurance companies begin covering the tests initially on a patient by patient basis, and some are covering the tests while some are not. But they do have a sales and marketing team in place that will be very active in the second half of the year. I asked her to give me a percentage of confidence that the BRAF and KRAS tests will be available and rolled out this year and she said she "had no reason to believe that by the end of 2015 the BRAF and KRAS tests will be commercialized". She also said that they are working with Medicare Part D to get the tests covered, but the problem is, that there is no exact code for the type of test that TROV has using urine as the test sample and measuring cancer load and mutational status. I brought up EXAS and BIOC, and she was aware of both, saying that EXAS has only one test, and bioc also uses a blood sample, but she stated that she thought the TROV tests provide much superior results. I will continue this in my next post. Less
Sentiment: Strong Buy
Sort: Newest | Oldest | Most Replied Collapse all replies
pgsjackson • Mar 9, 2015 4:37 PM
0users liked this postsusers disliked this posts1Reply
Great post. I am assuming, from your optimism, that when you said, she "had no reason to believe that by the end of 2015 the BRAF and KRAS tests will be commercialized" it was a typo. Just making sure you meant to say that she HAD reason to believe they will be commercialized...
1 Reply to pgsjackson
mgm2020 • Mar 9, 2015 6:13 PM
1users liked this postsusers disliked this posts1Reply
Can't believe I missed that. Yes, she said she had no reason to believe that by the end of 2015 the tests would NOT be commercialized. So---I took that to mean she had 100% confidence at this time.
Sentiment: Strong Buy
mgm2020 • Mar 9, 2015 3:24 PM Flag
2users liked this postsusers disliked this posts2Reply
I asked her about the HPV test that they have developed and she said that they are looking to "partner" on that globally. I do not know exactly what that means, but I like it. They are compiling more trial data, and the data that comes out this time will be on a much larger scale----in the hundreds of tests, and it will not be a prospective or retrospective study, but a blinded trial to verify precision and accuracy. It looks like the second half of the year is when everything should be taking place and she sounded very confident that the tests would be ramped up and commercialized AND covered by insurance by the end of this year. I see the upcoming "earnings" announcement as a non-even and basically clarification of what to expect for the remainder of this year. I also brought up the secondary and the 23% discount on the stock price and she basically said "that's what the market would bear" and the underwriters. But she said that the recovery in the stock price is encouraging also. That's all I have. Give her a call. She is willing to answer all of your questions. Less
Sentiment: Strong Buy
News 
Market Data 
Discover 
